1-3 of 3
Gerhard Glatting
Close
Sort by
Journal Articles

Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases

Clinical Trials & Observations
Ansgar S. Schulz, Gerhard Glatting, Manfred Hoenig, Catharina Schuetz, Susanne A. Gatz, Simon Grewendorf, Monika Sparber-Sauer, Rainer Muche, Norbert Blumstein, Gabriele Kropshofer, Meinolf Suttorp, Donald Bunjes, Klaus-Michael Debatin, Sven N. Reske, Wilhelm Friedrich
Journal: Blood
Blood (2011) 117 (17): 4642–4650.
https://doi.org/10.1182/blood-2010-06-284349
Published: 2011
Includes: Supplemental data
Journal Articles

Radioimmunotherapy for Myeloablation Before SCT in Paediatric Patients with Malignant and Non-Malignant Diseases.

Ansgar S. Schulz, Susanne Gatz, Catharina Schuetz, Norbert Blumstein, Gerhard Glatting, Thomas Kull, Sven Reske, Klaus-Michael Debatin, Wilhelm Friedrich
Journal: Blood
Blood (2007) 110 (11): 624.
https://doi.org/10.1182/blood.V110.11.624.624
Published: 2007
Journal Articles

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Clinical Trials & Observations
Donald Bunjes, Inga Buchmann, Christian Duncker, Ulrike Seitz, Jörg Kotzerke, Markus Wiesneth, Dagmar Dohr, Martin Stefanic, Andreas Buck, Stefanie V. Harsdorf, Gerhard Glatting, Wolfgang Grimminger, Tunca Karakas, Gerd Munzert, Hartmut Döhner, Lothar Bergmann, Sven N. Reske
Journal: Blood
Blood (2001) 98 (3): 565–572.
https://doi.org/10.1182/blood.V98.3.565
Published: 2001